Celldex Therapeutics buy Cantor Fitzgerald
Start price
12.10.23
/
50%
€25.00
Target price
12.10.24
€51.15
Performance (%)
51.20%
Price
08.05.24
€38.40
Summary
This prediction is currently active. The BUY prediction by Cantor_Fitzgerald for Celldex Therapeutics has seen massive gains of 51.20%. This prediction currently runs until 12.10.24. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Celldex Therapeutics | 0.524% | 0.524% |
iShares Core DAX® | 4.094% | 3.543% |
iShares Nasdaq 100 | 1.424% | 0.512% |
iShares Nikkei 225® | -1.572% | -4.633% |
iShares S&P 500 | 1.822% | 0.963% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics, Inc. (NASDAQ: CLDX) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $54.00 price target on the stock.
Ratings data for CLDX provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Celldex Therapeutics
Celldex Therapeutics
Start price
Target price
Perf. (%)
€38.80
22.03.24
22.03.24
€61.99
22.03.25
22.03.25
-1.03%
08.05.24
08.05.24
Celldex Therapeutics
Start price
Target price
Perf. (%)
€23.80
03.11.23
03.11.23
€48.43
03.11.24
03.11.24
61.34%
08.05.24
08.05.24
Celldex Therapeutics
Start price
Target price
Perf. (%)
€25.80
27.09.23
27.09.23
€51.25
27.09.24
27.09.24
46.51%
08.05.24
08.05.24
Celldex Therapeutics
Start price
Target price
Perf. (%)
€27.80
16.08.23
16.08.23
€49.46
16.08.24
16.08.24
38.13%
08.05.24
08.05.24